ACCESS – vACcine Covid-19 monitoring ReadinESS

The goal is to establish a European infrastructure prepared for the monitoring of the COVID-19 vaccines and for conducting specific studies, and to provide documented information about the feasibility to address different outcomes: coverage, safety and effectiveness.

Logo for prosjektet

Funding for ACCESS

European Medicines Agency

Partners of ACCESS project

  • University Utrecht, Netherlands
    • Key contact: Olaf Klungel
  • UMC Utrecht, Netherlands
    • Key contact: Miriam Sturkenboom
  • AEMPS, Spain
    • Key contact: Consuelo Huerta
  • University of Messina, Italy
    • Key contact: Gianluca Trifiro’
  • Aarhus University, Denmark
    • Key contact: Vera Ehrenstein
  • IDIAP-Jordi Gol, Spain
    • Key contact: Boni Bolibar
  • BIPS, Germany
    • Key contact: Ulrike HAug
  • FISABIO, Spain
    • Key contact: Javier Diez-Domingo
  • LAREB, Netherlands
    • Key contact: Agnes Kant
  • RTI-HS, USA
    • Key contact: Susana Perez-Gutthann
  • University of Oslo, Norway
    • Key contact: Hedvig Nordeng
  • Agenzia Regionale di Sanita Toscana, Italy
    • Key contact: Rosa Gini
  • SoSeTe-Pedianet, Italy
    • Key contact: Carlo Giaquinto
  • PHARMO, Netherlands
    • Key contact: Ron Herings
  • University of Bordeaux, France
    • Key contact: Cecile-Droz
  • VAC4EU, Belgium
    • Key contact: Patrick Mahy
Published June 19, 2020 7:20 AM - Last modified June 25, 2020 5:59 AM